Huntington disease (HD) |
Huntingtin |
6-34 (CAG) |
36-121 |
Transcriptial repressor, membrane trafficking, endocytosis |
Spinal and bulbar muscular atrophy (SBMA)/Kennedy's disease |
Androgen receptor |
9-36 (CAG) |
38-62 |
Nuclear receptor, Androgen response |
Dentatorubral-pallidoluysian atrophy |
Atrophin 1 |
7-34 (CAG) |
49-88 |
Nuclear receptor corepressor, Transcriptional corepressor |
SCA1 |
Ataxin-1, alt-ATXN1 |
6-39 (CAG) |
40-82 |
RNA processing, Transcription factor, Transcriptional corepressor, general repressor of transcription |
SCA2 and amyotrophic lateral sclerosis (ALS) |
Ataxin-2 |
15-24 (CAG) |
27-33 for ALS, 32-200 for SCA2 |
RNA binding protein |
SCA3, Machado-Joseph disease |
Ataxin-3 |
13-36 (CAG) |
61-84 |
Transcription factor, Transcriptional coactivator, Transcriptional repressor, Histone H2B deubiquitinase |
SCA6 |
α1A voltage-dependent calcium channel subunit, and α1ACT |
4-18 (CAG) |
19-33 |
Voltage-gated calcium channel, Transcription factor |
SCA7 |
Ataxin-7 |
4-35 (CAG) |
36-460 |
Integral member of SAGA complex, regulation of histone acetylation and ubiquitination. |
SCA17 |
TATA box binding protein (TBP) |
25-42 (CAG) |
47-63 |
General transcription factor, member of TFIID complex |